You are currently viewing a new version of our website. To view the old version click .

Emerging Pharmaceutical Strategies against Infectious Diseases

This special issue belongs to the section “Drug Targeting and Design“.

Special Issue Information

Dear Colleagues,

Infectious diseases persist as a global health challenge, constantly presenting new hurdles for effective treatment. This Special Issue seeks to showcase pioneering research on drug delivery systems, targeted therapies, and novel formulations combating diverse infectious agents.

We welcome contributions that underscore the integration of cutting-edge technologies such as nanomedicine, immunotherapy, and personalized drug design to tackle the evolving complexities of infectious diseases. Researchers are encouraged to offer insights into the challenges and prospects of developing effective antiviral, antibacterial, and antifungal agents. Join us in shaping the trajectory of pharmaceutical interventions in the battle against infectious diseases. Submit your contributions to this Special Issue and play a pivotal role in advancing this critical field.

We look forward to receiving your contributions. 

Dr. M. Auxiliadora Dea-Ayuela
Dr. Dolores Remedios Serrano
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antibiotic activity
  • antibacterial activity
  • antifungal activity
  • antiviral activity
  • antimicrobial drug development
  • vaccine innovation
  • host-targeted therapies
  • precision medicine in infectious diseases
  • nanotechnology in antimicrobial therapeutics
  • drug delivery for infections

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923